Is Agilent Technologies (A) overvalued or fairly valued?

MarketChacha shows Agilent Technologies's valuation in context — a forward P/E of about 20.5, a price-to-book of about 5.4 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is the share price of Agilent Technologies (A)?

Agilent Technologies last traded at $135.27 (+1.8% on the day), as of 7/22/2026 — a delayed quote shown for education, not investment advice.

Agilent Technologies

A · NYSE · Healthcare · United States

$135.27+1.8%

Delayed · as reported by Yahoo Finance · as of Jul 22, 2026, 5:19 PM

Snapshot

TickerA

ExchangeNYSE

SectorHealthcare

IndustryDiagnostics & Research

CountryUnited States

Employees18,000

HeadquartersSanta Clara, United States

Market cap$38.2B

P/B5.4

Volume1.01M

Websitewww.agilent.com

Filings tracked0

About Agilent Technologies

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Profile as reported by Yahoo Finance.

Who owns it

Insiders0.2%
Institutions94.2%
Public & other5.6%

1,543 institutional holders

As reported by Yahoo Finance.

Top holders

Blackrock Inc.9.17%
Vanguard Capital Management LLC6.51%
Vanguard Portfolio Management LLC5.08%
State Street Corporation4.52%
Massachusetts Financial Services Co.4.47%
T. Rowe Price Investment Management, Inc.3.18%
Geode Capital Management, LLC2.66%
Wellington Management Group, LLP2.57%

Largest institutional holders, as reported by Yahoo Finance (as of 3/31/2026).

What's expected next

Next quarter

Rev $2.0B · EPS 1.71

Est. earnings growth +7.7%

Next fiscal year

Rev $7.9B · EPS 6.61

Est. earnings growth +9.1%

Analyst consensus estimates — not the company's own guidance. As reported by Yahoo Finance.

$108.3552-wk range$160.27

Delayed · as reported by Yahoo Finance

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Ask MarketChacha about A

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed · as reported by yahoo finance) are delayed and shown for reference only. Verify with the linked sources before acting.